We are live on ! Find out more
HLF icon

Herbalife

223 hedge funds and large institutions have $7.46B invested in Herbalife in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 66 increasing their positions, 89 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 25

8% more funds holding

Funds holding: 206223 (+17)

4% less capital invested

Capital invested by funds: $7.79B → $7.46B (-$335M)

18% less funds holding in top 10

Funds holding in top 10: 119 (-2)

26% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 89

62% less call options, than puts

Call options by funds: $256M | Put options by funds: $681M

109.92% less ownership

Funds ownership: 194.13%84.22% (-110%)

Holders
223
Holders Change
+17
Holders Change %
+8.25%
% of All Funds
5.11%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.21%
New
45
Increased
66
Reduced
89
Closed
25
Calls
$256M
Puts
$681M
Net Calls
-$425M
Net Calls Change
-$204M
Name Holding Trade Value Shares
Change
Change in
Stake
GC
76
Guggenheim Capital
Illinois
$4.9M +$1.93M +36,720 +67%
Allianz Asset Management
77
Allianz Asset Management
Germany
$4.85M +$3.57M +67,943 +305%
PSUF
78
People's United Financial
Connecticut
$4.52M +$46.2K +879 +1%
AG
79
Aperio Group
California
$4.38M +$922K +17,530 +27%
Man Group
80
Man Group
United Kingdom
$4.11M +$1.54M +29,323 +62%
ECM
81
Element Capital Management
New York
$4.09M -$2.5M -47,628 -38%
Wells Fargo
82
Wells Fargo
California
$3.88M -$135K -2,575 -3%
EF
83
Empirical Finance
Pennsylvania
$3.68M +$3.6M +68,548 New
T. Rowe Price Associates
84
T. Rowe Price Associates
Maryland
$3.52M +$132K +2,514 +4%
Aviva
85
Aviva
United Kingdom
$3.46M -$16.2K -308 -0.5%
CG
86
Clinton Group
New York
$3.33M +$3.26M +61,943 New
GIA
87
Gateway Investment Advisers
Ohio
$3.28M -$847K -16,110 -21%
Royal London Asset Management
88
Royal London Asset Management
United Kingdom
$3.11M +$3.05M +57,936 New
ARTA
89
A.R.T. Advisors
New York
$3.1M +$3.03M +57,700 New
CIBC World Market
90
CIBC World Market
Ontario, Canada
$3.08M -$5.26M -100,000 -64%
CWM
91
CIBC World Markets
New York
$3.08M +$3.01M +57,326 New
GCP
92
GSA Capital Partners
United Kingdom
$2.84M +$78.4K +1,492 +3%
LCM
93
Landscape Capital Management
New Jersey
$2.66M -$780K -14,829 -23%
Jacobs Levy Equity Management
94
Jacobs Levy Equity Management
New Jersey
$2.42M +$2.37M +45,130 New
ACPU
95
Arrowgrass Capital Partners (US)
Delaware
$2.08M -$28.3M -537,528 -93%
SG Americas Securities
96
SG Americas Securities
New York
$1.96M -$249K -4,734 -12%
Citadel Advisors
97
Citadel Advisors
Florida
$1.88M -$17.4M -331,861 -90%
Jennison Associates
98
Jennison Associates
New York
$1.87M +$1.83M +34,811 New
JIR
99
James Investment Research
Ohio
$1.86M +$1.82M +34,675 New
Treasurer of the State of North Carolina
100
Treasurer of the State of North Carolina
North Carolina
$1.85M +$1.18M +22,514 +189%

HLF Hedge Fund Activity: Q2 2018 in Review

223 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Herbalife (HLF) for Q2 2018, worth a combined $7.46B — down 4.3% from $7.79B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new HLF positions and 25 closed out — a net gain of 20 holders — while 66 added to existing stakes and 89 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $154M. The largest seller was Icahn Carl, cutting an estimated $553M.

  • 223 institutional investors held Herbalife (HLF) as of Q2 2018, up from 206 in Q1 2018.
  • Funds reported $7.46B of Herbalife stock for Q2 2018, down 4.3% quarter-over-quarter.
  • 45 funds opened new Herbalife positions in Q2 2018 and 25 closed out, a net change of +20 holders.
  • The largest Herbalife buyer in Q2 2018 was Renaissance Technologies, an estimated $154M added.
  • The largest Herbalife seller in Q2 2018 was Icahn Carl, an estimated $553M sold.

Based on aggregated 13F filings for Q2 2018.